• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
Decoder.ca

Decoder.ca

Canadian Tech in 100 Words

 
  • About
  • News
  • Techtalent.ca
  • Dictionary
  • Contact

Aspect Biosystems Gains $72.75M Government Investment for Bioprinted Therapies

July 10, 2024 by Newsdesk

Vancouver’s Aspect Biosystems announced a $72.75 million investment from the Governments of Canada and British Columbia to support a $200 million project advancing their bioprinted tissue therapeutics. This funding will enhance Aspect’s biomanufacturing capabilities and therapeutic platform, targeting incurable diseases with innovative treatments.

Aspect’s collaboration with Novo Nordisk will be leveraged, focusing on diabetes, obesity, liver disease, and other metabolic disorders. CEO Tamer Mohamed emphasized the investment as a crucial step in regenerative medicine.

Want to know more? Check out the source code on Techcouver.

Filed Under: News Tagged With: Aspect Biosystems

Primary Sidebar

 

Stay in Touch

  • LinkedIn
  • RSS
  • Twitter

Copyright © 2025 Incubate Ventures | Techtalent.ca · Techcouver.com · Calgary.tech · Fintech.ca · CleanEnergy.ca | Privacy